Following a candidate gene approach, a recent study on a Lebanese population that also compared the prevalence of anti-T. gondii IgG in patients with schizophrenia and controls suggested that genetic variation in a peptidase involved in neuroinflammation could be implicated in the occurrence mechanism of this condition following T. gondii infection [32]. This evidence concerns the gene LAP3 and schizophrenia.